tiprankstipranks
Khiron Life Sciences Corp (KHRNF)
OTHER OTC:KHRNF
Holding KHRNF?
Track your performance easily

Khiron Life Sciences (KHRNF) Income Statement

172 Followers

Khiron Life Sciences Income Statement

Last quarter (Q3 2022), Khiron Life Sciences's total revenue was C$3.38M, a decrease of -3.81% from the same quarter last year. In Q3, Khiron Life Sciences's net income was C$-3.58M. See Khiron Life Sciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
C$ 16.14MC$ 12.79MC$ 8.02MC$ 9.58MC$ 891.68KC$ 0.00
Cost of Revenue
C$ 9.47MC$ 6.42MC$ 1.01MC$ 7.15MC$ 594.31KC$ 0.00
Gross Profit
C$ 6.67MC$ 6.37MC$ 7.01MC$ 2.44MC$ 297.36KC$ 0.00
Operating Expense
C$ 23.34MC$ 26.16MC$ 30.61MC$ 40.02MC$ 18.99MC$ 3.76M
Operating Income
C$ -16.67MC$ -19.79MC$ -23.60MC$ -37.58MC$ -18.69MC$ -3.76M
Net Non Operating Interest Income Expense
C$ -75.00KC$ 445.00KC$ 468.00K---
Other Income Expense
C$ -16.16MC$ -13.36MC$ 123.00KC$ 1.22MC$ -1.04MC$ -14.82K
Pretax Income
C$ -31.03MC$ -33.59MC$ -23.95MC$ -36.36MC$ -19.73MC$ -3.78M
Tax Provision
C$ -367.00KC$ -465.00KC$ 89.00KC$ 22.75KC$ 78.58KC$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ -30.66MC$ -33.13MC$ -24.04MC$ -36.38MC$ -19.81MC$ -3.78M
Basic EPS
C$ -0.13C$ -0.20C$ -0.20C$ -0.36C$ -0.42C$ -0.14
Diluted EPS
C$ -0.13C$ -0.20C$ -0.20C$ -0.36C$ -0.42C$ -0.14
Basic Average Shares
C$ 759.41MC$ 164.52MC$ 120.29MC$ 101.97MC$ 48.52MC$ 27.76M
Diluted Average Shares
C$ 759.41MC$ 164.52MC$ 120.29MC$ 101.97MC$ 48.52MC$ 27.76M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 15.48MC$ -32.58MC$ -31.62MC$ -47.16MC$ -19.58MC$ 3.76M
Net Income From Continuing And Discontinued Operation
C$ -30.66MC$ -33.13MC$ -24.04MC$ -36.38MC$ -19.81MC$ -3.78M
Normalized Income
C$ -30.52MC$ -18.85MC$ -17.60MC$ -26.57MC$ -13.29MC$ -3.78M
Interest Expense
------
EBIT
C$ -30.64MC$ -33.15MC$ -23.48MC$ -36.36MC$ -19.73MC$ -3.76M
EBITDA
C$ -28.68MC$ -32.03MC$ -22.32MC$ -35.42MC$ -19.39MC$ -3.76M
Currency in CAD

Khiron Life Sciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis